Clinical Trials Update: July 10, 2007
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
62269
A New Jersey court awards damages to Idaho couple in Vioxx case.Plus: SEC and OSC file complaints against former Nortel execs... Bush administration says it's fish farming season... and more.
256558
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday that it was halting the use of the painkiller Celebrex in a clinical trial on colorectal cancer patients after a study found an apparent increase in the risk of heart attack among those taking the drug.
362336
By Thomas Ginsberg, The Philadelphia Inquirer  Dec. 19--Wyeth Pharmaceuticals said today that the FDA has agreed to conduct a fast-track review of the company's new kidney cancer-fighting drug, Torisel.
433134
FRIDAY, Dec. 15  (HealthDay News) -- The  U.S. Food and Drug Administration Friday gave the green light to Celebrex for use in kids older than two as a treatment for juvenile rheumatoid arthritis.
700459
SALT LAKE CITY - Learning whether or not one method of surgery works better than another for patients with chondrosarcoma, a cancer of the cartilage, is the goal of a new clinical study opening this week at multiple sites around the US and Canada, with
414089
A website goes the extra mile to make sure voters aren & rsquo;t confused this Tuesday.  Also: West Virginia organizes the first public supercomputer & hellip;.  FDA keeps its eye on a new pain relief drug & hellip;. and more.
693379
questions over testing of a key HIV/AIDS drug before a US-backed roll-out of the treatment across the continent. Ingelheim to hide adverse effects of nevirapine when used to try to prevent mother-to-child HIV transmission.
362077
Clinical trial data released by pharmaceutical company Boehringer Ingelheim at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, DC, on its experimental protease inhibitor tipranavir show that the drug is effective
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
749165
New studies shed some light on these controversial heart treatments, but many questions remain. What patients need to know.
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.
401378
Surprising study results show that the popular heart drug doesn't live up to its claims  -  and three new trials are now underway
592462
roundup Plus: PC shipments up, but revenue less so, study says...BEA mobilizes corporate data...Web services outfits merge...Microsoft sets holiday Xbox bundle...PalmSource settles Digeo patent suit.
757229
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis. The companies said they plan on reporting phase 2 results Oct. 14. After phase 3, they hope to seek US regulatory approval in 2011 to market the drug, also known as alemtuzumab, to ...
303689
Acorda announces positive clinical trial data.
500493
SATURDAY, Jan. 29 (HealthDayNews) -- A new drug that targets pancreatic cancer in two ways is being tested by oncologists at the University of Southern California/Norris Comprehensive Cancer Center.